Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125919881 | 12591988 | 1 | I | 20160309 | 0 | 20160725 | 20160725 | DIR | 19.00 | YR | M | N | 140.00000 | LBS | 20160723 | N | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125919881 | 12591988 | 1 | PS | CLARAVIS | ISOTRETINOIN | 1 | Oral | N | D | 34027332A | 20170524 | 0 | 222 | DF | CAPSULE | BID | |||
| 125919881 | 12591988 | 3 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125919881 | 12591988 | 5 | C | MELATONIN | MELATONIN | 1 | 0 | ||||||||||||
| 125919881 | 12591988 | 7 | C | CITICOLINE | CITICOLINE | 1 | 0 | ||||||||||||
| 125919881 | 12591988 | 9 | C | L-TYROSINE | 2 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125919881 | 12591988 | 1 | Acne |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125919881 | 12591988 | DS |
| 125919881 | 12591988 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125919881 | 12591988 | Anhedonia | |
| 125919881 | 12591988 | Depression | |
| 125919881 | 12591988 | Sexual dysfunction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125919881 | 12591988 | 1 | 20160117 | 20160520 | 0 |